JDCA Releases First-of-Its-Kind Report of Companies Working on a Diabetes CureNEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The Juvenile Diabetes Cure Alliance (JDCA), a 501(c)(3) nonprofit focused on accelerating a cure for type 1 diabetes (T1D), announced the release of a comprehensive report of the companies in an advanced stage of cure research. The publication titled Cell Therapy & Immunomodulation Sector for Type 1 Diabetes, is the first of its kind to combine both a financial and diabetes impact assessment.
14th Annual State of the Cure for T1D Shows Major Development in Cure ResearchNEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Juvenile Diabetes Cure Alliance (JDCA), a 501(c)(3) nonprofit solely focused on accelerating a cure for type 1 diabetes, announced the release of the 14th annual State of the Cure for Type 1 Diabetes (SOTC). This is the first publication to highlight the shift of cell supply research from the nonprofit to the commercial domain.
